Extendicare Inc. (TSE:EXE – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as C$11.35 and last traded at C$11.31, with a volume of 84376 shares changing hands. The stock had previously closed at C$11.12.
Analysts Set New Price Targets
EXE has been the subject of several recent analyst reports. BMO Capital Markets set a C$11.00 target price on Extendicare and gave the company a “market perform” rating in a research note on Thursday, January 30th. Royal Bank of Canada raised their target price on Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research note on Thursday, November 28th. Finally, TD Securities raised their target price on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research note on Thursday, November 14th.
Check Out Our Latest Stock Analysis on Extendicare
Extendicare Stock Up 2.0 %
Extendicare Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be paid a $0.04 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a yield of 4.23%. Extendicare’s dividend payout ratio (DPR) is 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- EV Stocks and How to Profit from Them
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- What is a Death Cross in Stocks?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Why Invest in High-Yield Dividend Stocks?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.